DaVita Inc.
$213.36+0.2%YTD+87.4%1Y+52.0%
Mentions · last 7 days
25
Price updated 2h ago·X counts updated 1d ago
AI verdict & sentimentAI analysisGenerated by AI from underlying data
Today's AI verdict on what's driving $DVA, plus how loud the X conversation is and which way it's leaning.
What it does
Plain-English summary of the business — what they sell and how they make money.
Industry overviewAI analysisGenerated by AI from underlying data
Where Medical - Care Facilities sits in its cycle right now — and what that implies for $DVA.
Medical - Care Facilities
Healthcare labor shortages remain structural — hospital systems continue to rely on travel nursing and locum physician staffing to fill permanent workforce gaps that training pipelines cannot replenish at the required rate. Value-based care Medicare Advantage population management is the parallel model shift gaining traction.
Top industry ETF
$IHFiShares U.S. Healthcare Providers ETF
+13.4%YTD
+15.3%1Y
Fundamentals & catalyst
Profitability, valuation, and the next earnings event — at a glance, with rule-of-thumb signals.
Key ratios
P/E
21.0How much investors are paying per dollar of profit the company actually earned in the last 12 months. Lower means the stock looks cheaper relative to earnings.~15–25 is typical for the S&P 500; high-growth names trade 30+; hyper-growth or speculative can be 100+ or negative.ROIC
10.7%What percentage return the business earns on every dollar of capital (equity + debt) deployed in operations. The cleanest measure of business quality.Above ~15% is high-quality; consistently above 25% suggests a real moat. Below the company's cost of capital is value-destroying.Op margin
15.0%Operating profit (after sales, marketing, R&D, and overhead but before interest and taxes) as a percentage of revenue. The clearest view of how well the underlying business is run.Mature business above 20% is healthy; software businesses can run 30%+; commodity / retail businesses operate in single digits.FCF yield
10.9%Free cash flow (operating cash flow minus capex) divided by the company's market cap. The cash-on-cash return you'd get owning the whole business at today's price.Above ~5% is attractive; below ~2% means you're paying up for growth. Capital-light businesses (software) run higher than capital-heavy ones (utilities).P/S
1.0Same idea as P/E but per dollar of revenue. Useful for companies that aren't profitable yet, where P/E is meaningless.Under ~2 is cheap; software / SaaS often runs 8–15; well above 20 implies the market is pricing in very high future growth.ROE
-133%Net income as a percentage of shareholders' equity. Similar to ROIC but counts only the equity side.Above 20% is strong, but can be inflated by leverage — a heavily indebted company can show high ROE with weak underlying ROIC.Gross margin
31.1%Revenue minus the direct cost of producing what was sold, as a percentage of revenue. The first read on whether the product is structurally profitable.Software / SaaS is typically 70%+; consumer goods 30–50%; commodity / hardware businesses can be under 20%.D/E
-17.5Total debt divided by shareholders' equity. Measures how much the business runs on borrowed money versus owner capital.Under 1 is conservative; 1–2 is typical for mature businesses; over 2 is leveraged and more sensitive to interest rates.Past earnings
QuarterReportedActualEstimateSurprise
Q1 2026May 5, 2026$2.87$2.41+19.1%
Q4 2025Feb 2, 2026$3.40$3.24+4.9%
Q3 2025Oct 29, 2025$2.51$3.17-20.8%
Q2 2025Aug 5, 2025$2.95$2.70+9.3%
Next earningsWed, Aug 5·consensus EPS $3.84
Quarterly trend
QuarterRevenueYoYGrossOpEPSFCF
Q1 FY26$3.4B+6.0%31.4%14.1%$2.93$218.8M
Q4 FY25$3.6B+9.9%28.3%15.2%$2.51$395.3M
Q3 FY25$3.4B+4.8%31.8%14.8%$2.09$675.3M
Q2 FY25$3.4B+6.1%33.1%15.9%$2.62$203.3M
Forward consensus
FYRevenueRangeEPSRangeAnalysts
FY26$14.1B$13.9B – $14.3B$14.85$14.29 – $15.795
FY27$14.5B$14.3B – $14.9B$17.28$16.10 – $18.435
FY28$14.6B$14.3B – $14.9B$18.95$18.54 – $19.643
FY29$15.9B$15.6B – $16.3B$18.12$17.72 – $18.772
Setup & momentum
Volume, range, and moving-average position — the technical setup driving short-term moves.
Right now
Vol vs 30dToday's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.0.6×Today's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.
52w rangeWhere the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.98%Where the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.
vs 50d MALatest close vs the 50-day simple moving average. Positive = short-term trend is up.+15.8%Latest close vs the 50-day simple moving average. Positive = short-term trend is up.
vs 200d MALatest close vs the 200-day simple moving average. Positive = long-term trend is up.+48.5%Latest close vs the 200-day simple moving average. Positive = long-term trend is up.
Float & profile
FloatMid float · 62.8M shFree-float shares — the slice of issued stock actually available to trade. Lower buckets squeeze harder on a catalyst.Traded today0.8% of floatToday's volume as a percent of the free float. Above 5% on a single day is unusually high turnover for the available share count.
Insider activity
Recent open-market buys and sells by officers and directors — flagged when multiple insiders cluster.
Recent news
Latest headlines from major outlets, sourced and timestamped — context for whatever just moved.
DaVita HealthCare (DVA) Ascends While Market Falls: Some Facts to NoteDaVita Stock Benefits From Expanding Community-Based Kidney CareBest Growth Stocks to Buy for June 24thDVA vs. FMS: Which Dialysis Leader Is Better Positioned Now?3 Medical Stocks to Bet on Amid Market Optimism Following SpaceX IPO
More in Medical - Care Facilities
Peers in the same group — one click to compare setups, fundamentals, and chatter.
Voices on X · top 2 · last 7 days